Results 11 to 20 of about 2,967,291 (296)
Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy [PDF]
Liver Cancer, 2023 Masatoshi Kudo
doaj +2 more sources
Clinical and Translational Radiation Oncology, 2021 Background: Conservative approach has emerged as an option for the management of rectal cancer (RC) patients with a near or complete clinical response after neoadjuvant chemoradiotherapy (nCRT).
Giuditta Chiloiro +12 more
doaj +1 more source
THE COMPLETE CLINICAL RESPONSE IN RECTAL CARCINOMA AFTER CHEMO RADIATION
Pakistan Armed Forces Medical Journal, 2018 Objective: To determine the complete clinical response in rectal carcinoma after neoadjuvant chemo radiation. Study Design: Cross-sectional study.
Ammara Manzoor +5 more
doaj +1 more source
Management of the Complete Clinical Response [PDF]
Clinics in Colon and Rectal Surgery, 2017 AbstractOrgan preservation is considered in the management of selected patients with rectal cancer. Complete clinical response observed after neoadjuvant chemoradiation for rectal cancer is one of these cases. Patients who present complete clinical response are candidates to the watch-and-wait approach, when radical surgery is not immediately performed
Angelita, Habr-Gama +4 more
openaire +2 more sources
Frontiers in Oncology, 2022 The best treatment strategy for oesophageal cancer patients achieving a complete clinical response after neoadjuvant chemoradiation is a burning topic. The available diagnostic tools, such as 18F-FDG PET/CT performed routinely, cannot accurately evaluate
Letizia Deantonio +12 more
doaj +1 more source
Unresectable pancreatic adenocarcinoma with complete clinical response following chemoradiotherapy [PDF]
Turkish Journal of Surgery, 2015 Locally advanced or metastatic disease is present in 2/3s of patients with pancreatic cancer. Pancreatic cancer patients are assessed as resectable, potentially resectable (borderline) and unresectable according to pre-operative examinations. The chance for operability may be enhanced by using adjuvant-neoadjuvant systemic chemotherapy, radiotherapy or
Erol, Aksoy +5 more
openaire +2 more sources
Frontiers in Immunology, 2023 ObjectiveExamine patients with locally advanced rectal cancer (LARC) with deficient mismatch repair (dMMR) or microsatellite instability-high (MSI-H) who received neoadjuvant immunotherapy (nIT), and compare the outcomes of those who chose a watch-and ...
Renfang Yang +15 more
doaj +1 more source
Next Generation Sequencing Assay for Detection of Circulating HPV DNA (cHPV-DNA) in Patients Undergoing Radical (Chemo)Radiotherapy in Anal Squamous Cell Carcinoma (ASCC). [PDF]
, 2020 Background: Following chemo-radiotherapy (CRT) for human papilloma virus positive (HPV+) anal squamous cell carcinoma (ASCC), detection of residual/recurrent disease is challenging.
Augustin, Y +10 more
core +3 more sources
Road to organ preservation in locally advanced rectal cancer [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2017 Introduction. In the past 20 years there has been significant change in the treatment of rectal cancer, especially in terms of multimodal approach. Surgery is, at least for now, the mainstay treatment for resectable rectal cancer.
Nestorović Milica +2 more
doaj +1 more source
Frontiers in Oncology, 2022 Muscle-invasive bladder cancer (MIBC) is an aggressive disease requiring active management. Neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) is considered the standard treatment paradigm for MIBC patients, which could result in ...
Jie Wu +5 more
doaj +1 more source